These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 21790529

  • 1. Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia.
    Pitini V, Cascio A, Arrigo C, Altavilla G.
    Br J Haematol; 2012 Jan; 156(1):1. PubMed ID: 21790529
    [No Abstract] [Full Text] [Related]

  • 2. Cutaneous Mycobacterium chelonae infection in chronic lymphocytic leukaemia.
    Dungarwalla M, Field-Smith A, Jameson C, Riley U, Chapman A, Bunker CB, Dearden CE, Matutes E.
    Haematologica; 2007 Jan; 92(1):e5-6. PubMed ID: 17405741
    [No Abstract] [Full Text] [Related]

  • 3. [Visceral leishmaniasis as an opportunistic infection. Our experience].
    Masseo A, Raimo C, Foti G, Pellicanò S, Foti N.
    Minerva Med; 1989 Mar; 80(3):303-4. PubMed ID: 2717051
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients].
    Rodríguez-Wilhelmi P, Panizo C, Ruza E, Rocha E.
    Med Clin (Barc); 2001 Jan 13; 116(1):37-8. PubMed ID: 11181264
    [No Abstract] [Full Text] [Related]

  • 5. Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia.
    Roux C, Thyss A, Gari-Toussaint M.
    J Mycol Med; 2013 Dec 13; 23(4):270-3. PubMed ID: 24210582
    [Abstract] [Full Text] [Related]

  • 6. Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib.
    Piro E, Kropp M, Cantaffa R, Lamberti AG, Carillio G, Molica S.
    Ann Hematol; 2012 Nov 13; 91(11):1827-8. PubMed ID: 22584850
    [No Abstract] [Full Text] [Related]

  • 7. Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature.
    Bassetti M, Repetto E, Mikulska M, Miglino M, Clavio M, Gobbi M, Righi E, Viscoli C.
    J Chemother; 2009 Apr 13; 21(2):211-4. PubMed ID: 19423476
    [Abstract] [Full Text] [Related]

  • 8. Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).
    Hill BT, Caimi P, Kindwall-Keller T, Habecker B, Kalaycio M.
    Br J Haematol; 2014 Jan 13; 164(2):297-9. PubMed ID: 24131326
    [No Abstract] [Full Text] [Related]

  • 9. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
    Bacchu S, Fegan C, Neal J.
    Br J Haematol; 2007 Nov 13; 139(3):349. PubMed ID: 17784883
    [No Abstract] [Full Text] [Related]

  • 10. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.
    Vigna E, De Vivo A, Gentile M, Morelli R, Lucia E, Mazzone C, Recchia AG, Vianelli N, Morabito F.
    Transpl Infect Dis; 2010 Oct 13; 12(5):428-31. PubMed ID: 20534035
    [Abstract] [Full Text] [Related]

  • 11. Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression.
    Sylvan SE, Rossmann E, Mozaffari F, Porwit A, Norin S, Karlsson C, Hansson L, Lundin J, Österborg A.
    Br J Haematol; 2012 Dec 13; 159(5):608-12. PubMed ID: 23043283
    [No Abstract] [Full Text] [Related]

  • 12. Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia.
    Saadeh CE, Srkalovic G.
    Pharmacotherapy; 2008 Feb 13; 28(2):281-4. PubMed ID: 18225973
    [Abstract] [Full Text] [Related]

  • 13. Obinutuzumab (Gazyva) for chronic lymphocytic leukemia.
    Med Lett Drugs Ther; 2014 Nov 10; 56(1455):e114-5. PubMed ID: 25538980
    [No Abstract] [Full Text] [Related]

  • 14. Disseminated cryptococcosis, invasive aspergillosis, and mucormycosis in a patient treated with alemtuzumab for chronic lymphocytic leukaemia.
    Henn A, Mellon G, Benoît H, Roos-Weil D, Jauréguiberry S, Mordant P, Fekkar A, Caumes E.
    Scand J Infect Dis; 2014 Mar 10; 46(3):231-4. PubMed ID: 24450842
    [Abstract] [Full Text] [Related]

  • 15. Leishmania in a Patient with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia.
    Nicolas G, Koury E, Osman D, Saliba C, Nehme L, Mitri S, El Sayegh JA, Rached L, Khoury G.
    Am J Case Rep; 2018 May 01; 19():512-516. PubMed ID: 29712885
    [Abstract] [Full Text] [Related]

  • 16. Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case.
    Postorino MC, Bellantoni M, Catalano C, Caridi G, De Rosa M, Seck S, Enia G.
    J Nephrol; 2011 May 01; 24(4):530-4. PubMed ID: 21607915
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia.
    Dilhuydy MS, Jouary T, Demeaux H, Ravaud A.
    Br J Haematol; 2007 Jun 01; 137(6):490. PubMed ID: 17425643
    [No Abstract] [Full Text] [Related]

  • 19. Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients.
    Sirvent-von Bueltzingsloewen A, Marty P, Rosenthal E, Delaunay P, Allieri-Rosenthal A, Gratecos N, Cassuto JP.
    Bone Marrow Transplant; 2004 Mar 01; 33(6):667-8. PubMed ID: 14730334
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.